FY ended Dec 31, 2025 · figures in PESO except per-share rows
| Item | Current | Previous |
|---|---|---|
| Current assets | 3,805,647 | 3,536,127 |
| Total assets | 103,805,647 | 103,536,127 |
| Current liabilities | 4,511,567 | 4,472,919 |
| Total liabilities | 4,511,567 | 4,472,919 |
| Retained earnings/(deficit) | 41,773,325 | 41,542,453 |
| Stockholders' equity | 99,294,080 | 99,063,208 |
| Stockholders' equity (parent) | 87,110,696 | 86,908,152 |
| Book value per share | ₱198.59 | ₱198.13 |
| Item | Current | Previous |
|---|---|---|
| Gross revenue | 2,998,803(-0.1%) | 3,001,538 |
| Gross expense | 2,689,787 | 2,766,090 |
| Income/(loss) before tax | 309,016 | 235,448 |
| Net income/(loss) after tax | 230,872(+42.5%) | 162,069 |
| Net income/(loss), parent | 202,544 | 142,183 |
| EPS (basic) | ₱0.46 | ₱0.32 |
| EPS (diluted) | ₱0.46 | ₱0.32 |
BHI Holdings, Inc. (BH), formerly Consolidated Insurance Corporation, was incorporated on January 23, 1963. On November 4, 1999, the Securities and Exchange Commission approved the Company's change in corporate name to the present one, and its primary purpose from that of a non-life insurance company to that of an investment holding company.
BH aims to acquire equity plus interest in profitable corporations. However, due to the present economic condition, the Company has not been very active in investing and is only receiving interest income.
At present, BH has no principal products or services because it has not decided as to what product or service it will introduce to the market.
Average % return by calendar month, up to 2 yearsof history. Only a few years back each month, so this is descriptive color, not a predictable “month effect.”
BHI Holdings, Inc. trades on the Philippine Stock Exchange under the ticker symbol BH.
BH is listed in the Holding Firms sector of the Philippine Stock Exchange, where it ranks #27 of 31 by market capitalization. Across the whole exchange it is #255 of 282, at ₱490.0M.
PSEye has no cash dividend on record for BH in roughly the last two years. That is a statement about the corporate actions published on PSE Edge over that window, not a guarantee the company has never paid or will not pay one.
In its latest annual filing (fiscal year ended Dec 31, 2025), BH's revenue fell 0.1% and net income grew 42.5% versus the prior fiscal year. That's one year-over-year comparison, not a multi-year trend, so check the Balance sheet & income statement panel above for the full figures before drawing a conclusion.
PSEye doesn't rate stocks as good or bad buys. What this page can tell you is factual: where BH ranks by market cap (#255 of 282 on the exchange), its price history, valuation ratios, dividend record and recent company disclosures, all shown above. Whether that adds up to a good stock depends on your own criteria, and is worth researching beyond any single page, including this one.
PSEye is a data tracker, not a financial advisor, so it can't tell you whether to invest in BH or any other stock. The price, valuation, dividend and disclosure data on this page is meant to help you do your own research. Consider your own goals, risk tolerance and time horizon, and consult a licensed financial advisor before making an investment decision. If you're weighing a fixed, regular investment instead of a single lump sum, PSEye's DCA calculator shows how that strategy would have performed historically.
To buy BH shares, open an account with a PSE-accredited stockbroker (most Philippine banks and several standalone brokers offer online trading accounts), fund it, and place a buy order using the ticker symbol BH. A completed trade typically settles two trading days later (T+2). PSEye doesn't process trades or recommend a specific broker.
Delayed/EOD data, not real-time. Figures are statistics on past closing prices, not a forecast.